Evaluation of the inhibitory potential of bioactive compounds against SARS-CoV-2 by in silico approach
Description
CONTEXT: The COVID-19 (coronavirus disease 19) pandemic brought on by the SARS-CoV-2 outbreak (severe acute respiratory syndrome coronavirus 2) has stimulated the exploration of various available chemical compounds that could be used to treat the